InvestorsHub Logo
Followers 43
Posts 2425
Boards Moderated 0
Alias Born 02/09/2016

Re: XBRIANX post# 1076

Tuesday, 04/05/2016 7:55:54 PM

Tuesday, April 05, 2016 7:55:54 PM

Post# of 233035
XBRIANX- I'm not a physician but not apples to apples. JJ can concoct a "long acting" replacement for pills but CYDY's science is different... I will paste it.
"PRO 140 belongs to a new class of HIV/AIDS therapeutics -- viral-entry inhibitors -- that are intended to protect healthy cells from viral infection. PRO 140 is a fully humanized IgG4 monoclonal antibody directed against CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 blocks the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5. Importantly PRO 140 does not appear to interfere with the normal function of CCR5 in mediating immune responses."
Chump
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News